Dutton Associates Announces Investment Opinion: Chembio Diagnostics Inc. Coverage Initiated with Speculative Buy Rating.EL DORADO HILLS, Calif. -- In the first graph, first sentence of release dated Feb. 7, 2006, exchange and ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors should read: OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CEMI CEMI Center for Experimental Music and Intermedia (University of North Texas, Denton, TX) CEMI Communications-Electronics Maintenance Instruction (sted Nasdaq:CEMI). The corrected release reads: DUTTON ASSOCIATES ANNOUNCES INVESTMENT OPINION: CHEMBIO CHEMBIO Chemical and Biological Waste Treatment DIAGNOSTICS INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic. Antonym: dec. . COVERAGE INITIATED Coverage Initiated When a brokerage or analyst issues his/her first rating on a particular stock. Notes: The media usually states Joe's Brokerage initiates coverage on Boston Beer Company with a strong buy. WITH SPECULATIVE BUY RATING Dutton Associates initiates coverage of Chembio Diagnostics Inc. (OTCBB:CEMI) with a Speculative Buy rating and a 12-month price target of $1.00. The 18-page report by Dutton senior analyst Stephen L. Handley is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, and other leading financial portals. Chembio Diagnostics Inc. (CEMI) develops, manufactures and markets rapid diagnostic tests that aid in the detection of infectious diseases. Its current focus is on tests that aid in the diagnosis of HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Chagas disease, sales of which are now accelerating. About Dutton Associates Dutton Associates is one of the largest independent investment research firms in the U.S. Its 29 senior analysts are primarily CFAs and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 100 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors. The cost of enrollment in our one-year continuing research program is US $35,000 prepaid before commencement of our research activities. We received $35,000 from the Company for 4 quarterly Research Reports with coverage commencing on 2/7/2006. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion